GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,199,000 | -63.2% | 29,689 | -65.0% | 0.20% | -54.6% |
| Q3 2015 | $3,259,000 | +63.4% | 84,764 | +76.9% | 0.43% | +59.6% |
| Q2 2015 | $1,995,000 | +10.6% | 47,913 | +22.6% | 0.27% | +24.8% |
| Q1 2015 | $1,803,000 | +28.1% | 39,076 | +18.6% | 0.22% | +23.9% |
| Q4 2014 | $1,408,000 | -2.6% | 32,940 | +4.9% | 0.18% | -21.4% |
| Q3 2014 | $1,445,000 | +528.3% | 31,412 | +631.7% | 0.22% | +558.8% |
| Q2 2014 | $230,000 | -83.0% | 4,293 | -83.1% | 0.03% | -82.3% |
| Q1 2014 | $1,354,000 | -55.7% | 25,337 | -55.7% | 0.19% | -61.7% |
| Q4 2013 | $3,055,000 | +62.5% | 57,227 | +52.7% | 0.50% | +39.6% |
| Q3 2013 | $1,880,000 | +333.2% | 37,485 | +331.4% | 0.36% | +308.0% |
| Q2 2013 | $434,000 | – | 8,689 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |